Patent Yard Sign in
Canadian application, no grantCanada

Method and apparatus for analyzing the glycation of hemoglobin

CA 2108011 A1 · Owner: Chronomed, Inc. · Inventors: Saunders, Alexander

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

As red blood cells age their hemoglobin is progressively, glycosylated. This invention relates to analyzing the history of blood sugar metabolism over a period of several months by taking a blood sample, separating the cells into age-ordered cohorts determining glycohemoglobin levels in the cells of each cohort and, correlating glycohemoglobin levels with red blood cell age while, correcting for the reversibility of the Amadori rearrangement.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 16, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 16, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 16, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 16, 1992
GrantedNo grant recorded
Term endedMarch 16, 2012
Patent numberCA 2108011 A1
Classification (IPC)C12Q1/48 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedMarch 16, 1992Term endedMarch 16, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.